Isolation of goat milk small extracellular vesicles by novel combined bio-physical methodology

Front Bioeng Biotechnol. 2023 Sep 27:11:1197780. doi: 10.3389/fbioe.2023.1197780. eCollection 2023.

Abstract

Introduction: Goat milk is notable as a cost-effective source of exosomes, also known as small extracellular vesicles (sEVs). These nanoparticle-like structures are naturally secreted by cells and have emerged as potential diagnostic agents and drug delivery systems, also supported by their proven therapeutic effects. However, the complexity of goat milk and the lack of standardized protocols make it difficult to isolate pure sEVs. This work presents an optimized approach that combines well-established physical isolation methods with the biological treatment of milk with rennet. Methods: sEVs derived from goat milk were purified using a methodology that combines differential ultracentrifugation, rennet, and size-exclusion chromatography. This novel strategy was compared with two of the main methodologies developed for isolating extracellular vesicles from bovine and human milk by means of physico-chemical characterization of collected vesicles using Transmission Electron Microscopy, Western blot, Bradford Coomassie assay, Dynamic Light Scattering, Nanoparticle Tracking Analysis and Zeta Potential. Results: Vesicles isolated with the optimized protocol had sEV-like characteristics and high homogeneity, while samples obtained with the previous methods were highly aggregated, with significant residual protein content. Discussion: This work provides a novel biophysical methodology for isolating highly enriched goat milk sEVs samples with high stability and homogeneity, for their further evaluation in biomedical applications as diagnostic tools or drug delivery systems.

Keywords: differential ultracentrifugation; exosome characterization; exosomes; goat milk; isolation methods; small extracellular vesicles.

Grants and funding

This study has been funded by the Instituto de Salud Carlos III through the projects “PI20/01632” and “PT20/00044”, and co-funded by European Regional Development Fund (ERDF, “A way to make Europe”), and the PRISMAP project. This work has been also funded by Comunidad de Madrid through the project “S2022/BMD-7403 RENIM-CM.” The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX 2020–001041-S). MIG is funded by the Instituto de Investigación Sanitaria Gregorio Marañón, Intramural Programme for the Promotion of R&D&I 2021, Sub-programme “Predoctoral training contract.” MC-C is funded by a Miguel Servet type II research contract (CPII21/00007) from the Instituto de Salud Carlos III, Madrid, Spain. CC is funded by a predoctoral fellowship from Fundación Española de Trombosis y Hemostasia (FETH-SETH).